封面
市场调查报告书
商品编码
1390563

胎牛血清市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Fetal Bovine Serum Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年,全球胎牛血清市场规模达到9.48亿美元。展望未来, IMARC Group预计到2028年市场规模将达到13.333亿美元,2022-2028年复合年增长率(CAGR)为5.85%。

胎牛血清(FBS)是动物细胞培养基的主要成分,从牛的牛胎儿中获得。它含有多种细胞生长必需的营养和大分子因子。除此之外,它还含有胺基酸、糖、脂质、荷尔蒙和低丙种球蛋白含量。因此,它被广泛用于一系列应用,例如提供必需营养素并促进真核细胞培养中的细胞存活和增殖。它也用于研究、製造、生物技术药物以及控制人用和兽用疫苗。

胎牛血清市场趋势:

FBS 可用于产生干细胞,用于治疗因冠状病毒疾病 (COVID-19) 引起的急性和慢性肺损伤的患者。此外,由于它含有生长因子和抗体,可在实验室中利用以保持细胞存活以进行分裂、生长和进化,因此它在各种科学研究中发挥关键作用。再加上政府和私人机构为引进新型生物製药提供的资金增加,研发 (R&D) 活动显着增长,正在刺激全球对胎牛血清的需求。此外,由于急性和慢性疾病的日益流行,对生物製药产品的需求不断增加,也促进了市场的成长。除此之外,核心家庭的新兴趋势和不断上涨的收入水准正在积极影响宠物的拥有和人性化,从而导致全球越来越多地采用伴侣动物。随着动物性产品消费量的不断增加,预计将推动世界各地兽医诊断和疫苗中对胎牛血清的需求,以预防传染病。

本报告回答的关键问题

  • 2022年全球胎牛血清市场规模有多大?
  • 2023-2028年全球胎牛血清市场的预期成长率是多少?
  • COVID-19对全球胎牛血清市场有何影响?
  • 推动全球胎牛血清市场的关键因素是什么?
  • 基于该产品的全球胎牛血清市场的细分如何?
  • 基于应用的全球胎牛血清市场的细分如何?
  • 基于最终用户的全球胎牛血清市场的细分如何?
  • 全球胎牛血清市场的重点区域有哪些?
  • 全球胎牛血清市场的主要参与者/公司有哪些?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球胎牛血清市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章:按产品分類的市场区隔

  • 木炭剥离
    • 市场走向
    • 市场预测
  • 色谱法
    • 市场走向
    • 市场预测
  • 透析胎牛血清
    • 市场走向
    • 市场预测
  • 外泌体耗尽
    • 市场走向
    • 市场预测
  • 干细胞
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章:按应用分類的市场区隔

  • 生物製药
    • 市场走向
    • 市场预测
  • 细胞培养
    • 市场走向
    • 市场预测
  • 人类和动物疫苗生产
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章:最终用户的市场区隔

  • 生物技术和製药公司
    • 市场走向
    • 市场预测
  • 学术机构
    • 市场走向
    • 市场预测
  • 研究实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章:按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章:价值链分析

第 12 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章:价格分析

第14章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Atlas Biologicals Inc.
    • Biological Industries (Sartorius AG)
    • Bio-Techne Corporation
    • BioWest
    • Bovogen Biologicals Pty Ltd.
    • General Electric Company
    • HiMedia Laboratories
    • Merck KGaA
    • PAN-Biotech
    • Rocky Mountain Biologicals
    • TCS Biosciences Ltd
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4345

Abstract

The global fetal bovine serum market size reached US$ 948.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,333.3 Million by 2028, exhibiting a growth rate (CAGR) of 5.85% during 2022-2028.

Fetal bovine serum (FBS) is a major component of animal cell culture media, which is obtained from bovine fetuses of cows. It has several nutritional and macromolecular factors that are essential for cell growth. Besides this, it also comprises amino acids, sugars, lipids, hormones, and low gamma globulin content. As a result, it is widely utilized in a range of applications, such as providing essential nutrients and facilitating cell survival and proliferation in eukaryotic cell culture. It is also used in research, manufacturing, biotech drugs, and controlling human and veterinary vaccines.

Fetal Bovine Serum Market Trends:

FBS finds application in generating stem cells for treating patients suffering from acute and chronic lung damage due to coronavirus disease (COVID-19). In addition, as it contains growth factors and antibodies that can be utilized in laboratories to keep cells alive for dividing, growing, and evolving, it plays a pivotal role in various scientific research. This, along with significant growth in the research and development (R&D) activities on account of increasing funding by governing and private agencies to introduce novel biopharmaceuticals, is catalyzing the demand for FBS worldwide. Furthermore, the escalating demand for biopharma products on account of the growing prevalence of acute and chronic diseases is contributing to the growth of the market. Apart from this, the emerging trend of nuclear families and inflating income levels are positively influencing pet ownership and humanization, which is resulting in the increasing adoption of companion animals across the globe. This, along with the rising consumption of animal-derived products, is anticipated to fuel the need for FBS in veterinary diagnostics and vaccines to prevent infectious diseases around the world.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global fetal bovine serum market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Charcoal Stripped

Chromatographic

Dialyzed Fetal Bovine Serum

Exosome Depleted

Stem Cell

Others

Breakup by Application:

Biopharmaceuticals

Cell Culture

Human and Animal Vaccine Production

Others

Breakup by End User:

Biotechnology and Pharmaceutical Companies

Academic Institutes

Research Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Atlas Biologicals Inc., Biological Industries (Sartorius AG), Bio-Techne Corporation, BioWest, Bovogen Biologicals Pty Ltd., General Electric Company, HiMedia Laboratories, Merck KGaA, PAN-Biotech, Rocky Mountain Biologicals, TCS Biosciences Ltd and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global fetal bovine serum market in 2022?
  • 2. What is the expected growth rate of the global fetal bovine serum market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global fetal bovine serum market?
  • 4. What are the key factors driving the global fetal bovine serum market?
  • 5. What is the breakup of the global fetal bovine serum market based on the product?
  • 6. What is the breakup of the global fetal bovine serum market based on the application?
  • 7. What is the breakup of the global fetal bovine serum market based on the end user?
  • 8. What are the key regions in the global fetal bovine serum market?
  • 9. Who are the key players/companies in the global fetal bovine serum market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fetal Bovine Serum Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Charcoal Stripped
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chromatographic
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dialyzed Fetal Bovine Serum
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Exosome Depleted
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Stem Cell
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biopharmaceuticals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cell Culture
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Human and Animal Vaccine Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Biotechnology and Pharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Atlas Biologicals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Biological Industries (Sartorius AG)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-Techne Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 BioWest
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bovogen Biologicals Pty Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 HiMedia Laboratories
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 PAN-Biotech
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rocky Mountain Biologicals
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 TCS Biosciences Ltd
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Fetal Bovine Serum Market: Major Drivers and Challenges
  • Figure 2: Global: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Fetal Bovine Serum Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Fetal Bovine Serum Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Fetal Bovine Serum Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Fetal Bovine Serum Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Fetal Bovine Serum (Charcoal Stripped) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Fetal Bovine Serum (Charcoal Stripped) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Fetal Bovine Serum (Chromatographic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Fetal Bovine Serum (Chromatographic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Fetal Bovine Serum (Dialyzed Fetal Bovine Serum) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Fetal Bovine Serum (Dialyzed Fetal Bovine Serum) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Fetal Bovine Serum (Exosome Depleted) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Fetal Bovine Serum (Exosome Depleted) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Fetal Bovine Serum (Stem Cell) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Fetal Bovine Serum (Stem Cell) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Fetal Bovine Serum (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Fetal Bovine Serum (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Fetal Bovine Serum (Biopharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Fetal Bovine Serum (Biopharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Fetal Bovine Serum (Cell Culture) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Fetal Bovine Serum (Cell Culture) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Fetal Bovine Serum (Human and Animal Vaccine Production) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Fetal Bovine Serum (Human and Animal Vaccine Production) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Fetal Bovine Serum (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Fetal Bovine Serum (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Fetal Bovine Serum (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Fetal Bovine Serum (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Fetal Bovine Serum (Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Fetal Bovine Serum (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Fetal Bovine Serum (Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Fetal Bovine Serum (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Fetal Bovine Serum (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Fetal Bovine Serum (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Fetal Bovine Serum Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Fetal Bovine Serum Industry: SWOT Analysis
  • Figure 86: Global: Fetal Bovine Serum Industry: Value Chain Analysis
  • Figure 87: Global: Fetal Bovine Serum Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fetal Bovine Serum Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Fetal Bovine Serum Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Fetal Bovine Serum Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Fetal Bovine Serum Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Fetal Bovine Serum Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Fetal Bovine Serum Market: Competitive Structure
  • Table 7: Global: Fetal Bovine Serum Market: Key Players